Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Article



The use of multicomponent ear drops in the treatment of otitis of various etiologies in animals

Mikhail Vladimirovich Arisov, Evgenia Nikolaevna Indyuhova, Gulnara Bakitovna Arisova.

Abstract
Objective: The objective of this study was to investigate the efficacy of newly developed multi¬component ear drops for the treatment of otitis caused by parasites, bacteria, and fungi in dogs, cats, ferrets, fancy rabbits, and foxes.
Materials and Methods: A new drug for veterinary use was developed that contained levofloxacin hemihydrate (0.3%), clotrimazole (0.1%), dexamethasone sodium phosphate (0.1%), and mox¬idectin (0.01%). In the initial stage of otoacariasis (or the ear form of psoroptic scab), the drug was used twice with an interval of 5–7 days. When otoacariasis (psoroptic scab) was complicated by otitis of bacterial and/or fungal etiology, the drug was used as follows: instilled once a day, within 10–14 days in the ear canal for 2–5 drops of the drug. The study of therapeutic efficacy was per¬formed on cats, dogs, ferrets, foxes, and fancy rabbits with ear pathology.
Results: The recovery of cats, ferrets, dogs, and foxes after the double use of ear drops during otoacariasis was established. In the ear form of psoroptic scab in fancy rabbits after treatment, Psoroptes cuniculi mites were not detected. The specific (antimicrobial and antifungal) activity of the drug was confirmed in vivo using the following scheme of drug use: the drug was instilled once a day, within 10–14 days in the ear canal, 2–5 drops of the drug in animals with external otitis and otitis media.
Conclusion: The rational combination of active components developed in this study is effective and safe for use in animals with microbial diseases of the ears.

Key words: Otitis; animals; moxidectin; levofloxacin; clotrimazole; dexamethasone



Similar Articles

Vascular Imaging in Small Animals Using Clinical Ultrasound Scanners.
Zaw AM, Shangguan R, Yao Y, Jeong Y, Yiu BYS, Chee AJY, Yu ACH, Yim EKF
Methods in molecular biology (Clifton, N.J.). 2022; 2375(): 191-201

How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma.
Morris TCM, Drake MB, Kettle PJ, McGuigan T, Leahy M, O'Dwyer M, Enright H, O'Shea T, Popat R, Oakervee HE, Yong K, Cavenagh JD, Cairns DA, Alvarez-Iglesias A, Cook G
Clinical hematology international. 2021; 3(1): 27-33

Direct P70S6K1 inhibition to replace dexamethasone in synergistic combination with MCL-1 inhibition in multiple myeloma.
Spaan I, Timmerman LM, Kimman T, Slomp A, Cuenca M, van Nieuwenhuijzen N, Moesbergen LM, Minnema MC, Raymakers RA, Peperzak V
Blood advances. 2021; 5(12): 2593-2607

Sea turtle demand in China threatens the survival of wild populations.
Lin L, Li S, Chen M, Parham JF, Shi H
iScience. 2021; 24(6): 102517

Component resolved diagnosis using guinea-pig allergens elucidates allergen sensitization profiles in allergy to furry animals.
Swiontek K, Kler S, Lehners C, Ollert M, Hentges F, Hilger C
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunol. 2021; ():


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites